References for Annex 1

  1. Moayedi-Nia S, Barss L, Oxlade O, Valiquette C, Ly MX, Campbell JR et al. The mTST – an mHealth approach for training and quality assurance of tuberculin skin test administration and reading. PLoS One. 2019;14(4):e0215240 (
  2. Menzies D, Doherty T. Diagnosis of latent tuberculosis infection. In: Raviglione M (ed), Reichman and Hershfield’s tuberculosis, a comprehensive international approach. New York: Informa Healthcare USA; 2006:215–63 (
  3. The WHO standard tuberculin test. Geneva: World Health Organization; 1963 (
  4. C-TST package insert. China: Anhui Zhifei Longcom; 2022.
  5. Diaskintest package insert. Russian Federation: Generium; 2022.
  6. Cy-Tb package insert. India: Serum Institute; 2022.
  7. Alsdurf H, Hill P, Matteelli A, Getahun H, Menzies D. The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(11):1269 (
  8. Sokal J. Measurement of delayed skin-test responses. New Eng J Med. 1975;293:501–2 (
  9. Hanson M, Comstock G. Efficacy of hydrocortisone ointment in the treatment of local reactions to tuberculin skin tests. Am Rev Respir Dis. 1968;97:472–3 (
  10. Lewinsohn D, Leonard M, Lobue P. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64(2):111–5 (
  11. Campbell J, Pease C, Daley P, Pai M, Menzies D. Diagnosis of tuberculosis infection. In: Menzies D (ed), Canadian tuberculosis standards – 8th edition. Ottawa: Canadian Thoracic Society; 2022:49–65 (

Book navigation